BNTC · Benitec Biopharma Inc.
AI read · Neutral
The AI's read
This changes who checks Benitec's accounts, but the filing gives no new information about its medicines, research, or sales. It therefore does not change the company outlook.
Benitec completed the appointment of EY as its accountant for the year ending June 30, 2027. The filing gives no new information about its medicines, research, or sales, so it does not change the company outlook.
This changes who checks Benitec's accounts, but the filing gives no new information about its medicines, research, or sales. It therefore does not change the company outlook.
Follow Benitec Biopharma Inc. (BNTC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BNTC